Estimated incidence of serious complications 6 months after the surgical procedure
MUS alone: 3.5% (95% CI, 2.0 to 5.0%)
MUS with prolapse surgery: 7.0% (95% CI, 2.8 to 11.3%)
Vaginal native tissue repair: 1.7% (95% CI, 0.0 to 3.8%)
Transvaginal mesh: 2.8% (95% CI, 0.9 to 4.6%)
Laparoscopy with mesh: 1.0% (95% CI, 0.1 to 1.9%)
Several MUS complications were related to sling adjustments (loosening or division)
Most complications were related to intraoperative bladder injuries during vaginal surgery resulting in discontinuation of the mesh or sling placement
Early complications: Bladder voiding after MUS accounted for 50% of early complications
Later complications: Vaginal exposure of either MUS or mesh
More often when placed vaginally vs via laparoscope
SUI or POP surgery complications are rare
While an additional surgical procedure will be
classified as a complication, the authors note that one of the benefits of MUS
for SUI is the ability to adjust the sling, which is not possible with other
procedures (e.g., retropubic colposuspension or traditional sling)
Monitoring surgical outcomes including use of mesh
and other materials is of value | Long-term follow up is necessary
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan